Recent Updates
Recently added Catalysts
NMTC Positive Sentiment Score: 70/100

NeuroOne to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Provide Corporate Update on December 14

Thursday, December 7, 2023 1 min read
Key Takeaway: NeuroOne Medical Technologies Corporation (NMTC) plans to host a conference call on December 14, 2023, to discuss its financial results for the fourth quarter and fiscal year ending September 30, 2023. The conference aims to provide a corporate update and insights into the company’s operations and strategies in advancing medical technologies for neurological disorders. NeuroOne specializes in developing minimally invasive solutions for treating conditions such as epilepsy and chronic pain among others. Interested participants can join the call via provided dial-in numbers.

Market Sentiment Analysis

POSITIVE FACTORS

  • NeuroOne is preparing to report promising advancements in its financial results.
  • The company focuses on innovative treatments for various neurological disorders.
  • The upcoming conference call represents an opportunity for stakeholders to gain insights into the company's progress.

Full Press Release Details

EDEN PRAIRIE, Minn., Dec. 07, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fourth quarter and fiscal year ended September 30, 2023, and provide a corporate update, on December 14, 2023 at 5:00 PM Eastern Time.
Conference Call and Webcast Information:
Thursday, December 14, 2023 – 5:00 PM Eastern Time
Participant Dial-In:
877-405-1216 / +1 201-689-8336
877-660-6853 / 201-612-7415
Available through December 28, 2023
Available for 12 months
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com.

Tags

NeuroOne Medical Technologies
medical technology company

Frequently Asked Questions

When will NeuroOne host its financial results conference call?

NeuroOne will host its conference call on December 14, 2023, at 5:00 PM ET.

What is the focus of NeuroOne Medical Technologies?

NeuroOne specializes in minimally invasive solutions for neurological disorders.

Which conditions does NeuroOne aim to improve treatments for?

NeuroOne targets epilepsy, Parkinson's, dystonia, chronic pain, and more.

How long will the conference call be available for access?

The call will be available until December 28, 2023, for 12 months.

Where can I find more information about NeuroOne?

More details are available on NeuroOne's website at nmtc1.com.

Tags: NMTC Viatris Investor Conferences Healthcare NeuroOne financial results neurological disorders medical technology
Last updated: Dec 7, 2023